About BioImage
BioImage is a company based in Copenhagen (Denmark) founded in 1999 was acquired by Thermo Fisher Scientific in April 2006. BioImage has raised $30.47 million across 2 funding rounds from investors including Thermo Fisher Scientific, Novo Nordisk and Apax Partners. BioImage operates in a competitive market with competitors including Lodestone Biomedical, BioAmp Diagnostics, ACS Biomarker, HAWK Biosystems and Araceli Biosciences, among others.
- Headquarter Copenhagen, Denmark
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$30.47 M (USD)
in 2 rounds
-
Latest Funding Round
$13.47 M (USD), Series B
Jan 23, 2002
-
Investors
Thermo Fisher Scientific
& 4 more
-
Employee Count
Not available
-
Acquired by
Thermo Fisher Scientific
(Apr 26, 2006)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BioImage
BioImage has successfully raised a total of $30.47M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $13.47 million completed in January 2002. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BioImage
BioImage has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Thermo Fisher Scientific, Novo Nordisk and Apax Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Equity investments are focused on tech, services, and consumer sectors.
|
Locked | Locked | Locked | |
|
Early stage venture capital firm investing in US
|
Locked | Locked | Locked | |
|
Private equity and venture capital fund focused on the healthcare sector
|
Locked | Locked | Locked |
Investor details for BioImage
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioImage
Investment portfolio details for BioImage
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioImage
Detailed financials for BioImage
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioimage Comparisons
Peer comparison for BioImage
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioImage
BioImage operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lodestone Biomedical, BioAmp Diagnostics, ACS Biomarker, HAWK Biosystems and Araceli Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of magnetic nanoparticle platform technology for in vivo biomarker monitoring in immuno-oncology
|
|
| Locked | Locked | Locked |
Developers of diagnostic tests that help to treat patient with a specific antibiotic
|
|
| Locked | Locked | Locked |
Novel biomarkers for cardiac disease are discovered, validated, and commercialized.
|
|
| Locked | Locked | Locked |
Clinical assays are developed for quantifying novel biomarkers in samples.
|
|
| Locked | Locked | Locked |
Scientific tools for tissue and cell-based biomarker discovery are developed.
|
Detailed competitors of BioImage
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioimage
Complete news archive for BioImage
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioImage
BioImage was founded in 1999.
BioImage is headquartered in Copenhagen, Denmark.
BioImage is a funded company, having raised a total of $30.47M across 2 funding rounds to date.
BioImage was founded in 1999 in Copenhagen, Denmark, within the biotechnology sector. Proprietary bioassays are developed and sold to biopharmaceutical companies and research institutions, with contract-based development services also provided. Broad patents cover Enhanced GFP, GFP-based biosensors, and protein fusions to luminophores, enabling translocation monitoring in cells for drug discovery. This intellectual property supports collaborations and out-licensing with industry partners.
BioImage's top competitors include Araceli Biosciences, Lodestone Biomedical and BioAmp Diagnostics.
BioImage has 5 investors. Key investors include Thermo Fisher Scientific, Novo Nordisk, Apax Partners, Abingworth, and Novo Holdings.